NHLBI Funding & Research Opportunities and Announcements for January 25, 2019

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

 

Notices

Additional Information Regarding RFA-OD-18-001 "Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)" and RFA-OD-18-003 "Tobacco Regulatory Science (R21 Clinical Trial Optional)"

(NOT-OD-19-047) Office of Disease Prevention

Request for Information (RFI): Soliciting Additional Input to the NIH 2018 Tribal Consultation on the Opioid Crisis in Indian Country

(NOT-OD-19-059) National Institutes of Health

Notice of Intent to Publish the Reissuance of RFA-OD-18-002 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"

(NOT-OD-19-062) National Heart, Lung, and Blood Institute

The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) Announces Pacific Regional Workshop on Sexual and Gender Minority (SGM)-Related Research (NOT-OD-19-064) National Institutes of Health

Notice of OBSSR Participation in RFA-DA-19-035, "HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16-30) (UG3/UH3 Clinical Trial Required)"

(NOT-OD-19-066) Office of Behavioral and Social Science Research

Notice of NIAAA's participation in PAR-19-133, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15-Clinical Trial Not Allowed)

(NOT-AA-19-001) National Institute on Alcohol Abuse and Alcoholism

Notice of NIAAA's participation in PAR-19-134, Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

(NOT-AA-19-002) National Institute on Alcohol Abuse and Alcoholism

Notice of NIAAA's participation in PAR-19-135, Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

(NOT-AA-19-003) National Institute on Alcohol Abuse and Alcoholism

Notice of NIDCD Participation in PA-19-165 "Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)"

(NOT-DC-19-005) National Institute on Deafness and Other Communication Disorders

Notice of NHLBI Participation in PA-19-165 "Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)"

(NOT-HL-19-675) National Heart, Lung, and Blood Institute

 

Requests for Applications

NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)

(RFA-HL-20-011) National Heart, Lung, and Blood Institute

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

(RFA-HL-20-012) National Heart, Lung, and Blood Institute

Program Announcements

Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial Optional)

(PA-19-166) National Heart, Lung, and Blood Institute

Development and Validation of Advanced Mammalian Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)

(PAR-19-167) National Heart, Lung, and Blood Institute